DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are sixteen patents protecting this drug.
This drug has fifty-one patent family members in thirteen countries.
The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.
A generic version of XYOSTED (AUTOINJECTOR) was approved as testosterone enanthate by WATSON PHARMS INC on December 31st, 1969.
Summary for XYOSTED (AUTOINJECTOR)
|Country||Patent Number||Estimated Expiration|
|Spain||2763633||Try Before You Buy|
|World Intellectual Property Organization (WIPO)||0009186||Try Before You Buy|
|Canada||2900672||Try Before You Buy|
|Australia||2013203784||Try Before You Buy|
|Austria||281195||Try Before You Buy|
|European Patent Office||2833944||Try Before You Buy|
|>Country||>Patent Number||>Estimated Expiration|